ZNTL icon

Zentalis Pharmaceuticals
ZNTL

Overview Fund Activity

106 hedge funds and large institutions have $1.29B invested in Zentalis Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 48 increasing their positions, 30 reducing their positions, and 20 closing their positions.

Holders
106
Holders Change
-14
Holders Change %
-11.67%
% of All Funds
1.71%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.08%
New
6
Increased
48
Reduced
30
Closed
20
Calls
$1.58M
Puts
$24K
Net Calls
+$1.56M
Net Calls Change
-$2.23M

Top Buyers

1
Capital International Investors
1
Capital International Investors
California
$61.4M
2
APM
2
Avidity Partners Management
Texas
$104M
3
Wellington Management Group
3
Wellington Management Group
Massachusetts
$72.9M
4
SI
4
Sofinnova Investments
California
$20.2M
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$159M

Top Sellers

1
Axa
1
Axa
France
$0
2
AAA
2
Affinity Asset Advisors
New York
$0
3
WP
3
Woodline Partners
California
$2.95M
4
NIP
4
Nicholas Investment Partners
California
$0
5
Walleye Capital
5
Walleye Capital
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
MCMC
1
Matrix Capital Management Company
New Hampshire
$185M 9,199,973 – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$159M 7,909,176 +339,570 +4%
APM
3
Avidity Partners Management
Texas
$104M 5,150,000 +926,900 +22%
Vanguard Group
4
Vanguard Group
Pennsylvania
$83.8M 4,160,149 +53,888 +1%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$72.9M 3,618,493 +496,129 +16%
BlackRock
6
BlackRock
New York
$69.9M 3,472,179 +136,113 +4%
State Street
7
State Street
Massachusetts
$62.1M 3,084,137 +233,963 +8%
Capital International Investors
8
Capital International Investors
California
$61.4M 3,048,182 +3,048,182 New
TCM
9
Tybourne Capital Management
Hong Kong
$44.9M 2,231,427 -70,344 -3%
T. Rowe Price Investment Management
10
T. Rowe Price Investment Management
Maryland
$44.5M 2,210,442 +1,773 +0.1%
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$43.8M 2,176,700 -41,040 -2%
EAM
12
Eventide Asset Management
Massachusetts
$43.4M 2,156,515 +295,515 +16%
DCMIC
13
Decheng Capital Management III (Cayman)
Cayman Islands
$36.7M 1,824,583 – –
AllianceBernstein
14
AllianceBernstein
Tennessee
$27.5M 1,365,498 +33,614 +3%
Federated Hermes
15
Federated Hermes
Pennsylvania
$24.4M 1,211,600 +125,000 +12%
Primecap Management
16
Primecap Management
California
$22.8M 1,130,170 -49,530 -4%
SI
17
Sofinnova Investments
California
$20.2M 1,004,045 +420,688 +72%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$17.3M 857,217 +21,007 +3%
IHAM
19
Integral Health Asset Management
New York
$15.1M 750,000 +200,000 +36%
Capital World Investors
20
Capital World Investors
California
$13.8M 683,000 – –
Citadel Advisors
21
Citadel Advisors
Florida
$12.8M 637,720 +84,919 +15%
Northern Trust
22
Northern Trust
Illinois
$8.46M 420,044 +3,002 +0.7%
Allspring Global Investments
23
Allspring Global Investments
North Carolina
$7.95M 394,534 -633 -0.2%
Goldman Sachs
24
Goldman Sachs
New York
$7.86M 390,382 +52,050 +15%
Charles Schwab
25
Charles Schwab
California
$6.76M 335,757 +12,254 +4%
1
2 3 4 5